Navigation Links
FGX International to Present at the Oppenheimer 8th Annual Consumer Growth Conference
Date:7/2/2008

SMITHFIELD, R.I., July 2 /PRNewswire-FirstCall/ -- FGX International (Nasdaq: FGXI), a leading designer and marketer of non-prescription reading glasses, sunglasses and costume jewelry, today announced that Alec Taylor, Chief Executive Officer, Jack Flynn, President and Anthony DiPaola, Chief Financial Officer will be presenting at the Oppenheimer 8th Annual Consumer Growth Conference on Tuesday, July 8, 2008 at The Four Seasons Hotel in Boston.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071025/NETH104LOGO )

FGX International's presentation is scheduled for 11:25 - 11:55 A.M. ET. The presentation will be webcast live and archived online until July 15, 2008 at http://www.veracast.com/webcasts/opco/consumer08/78104398.cfm

About FGX International

FGX International Holdings Limited (Nasdaq: FGXI) is a leading designer and marketer of non-prescription reading glasses, sunglasses and costume jewelry with a portfolio of established, highly recognized eyewear brands including Foster Grant(R), Magnivision(R), Angel(TM), Gargoyles(R), and Anarchy(R).

Contact Information:

Investor Relations: FGXI:

Idalia Rodriguez Anthony DiPaola

ICR Inc. Chief Financial Officer

203-682-8264 401-719-2253


'/>"/>
SOURCE FGX International
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. 2008 International Federation of Adipose Therapeutics and Science (IFATS) Conference Date Set
2. QRxPharma Begins Trading on the International OTCQX
3. BioTime, Inc. and Embryome Sciences, Inc. Launch Embryome.com and the International Embryome Initiative
4. New York Resident Elected President of Lions Clubs International
5. The Second International Conference on Signs of Autism in Infants: Changing Outcomes through Early Identification and Intervention, October 11 and 12, 2008. Save the Date!
6. International Association for Dental Research presents awards and fellowships
7. International Dental Research Association meets in Toronto
8. NSF International Certifies Purity of Four Mannatech Products
9. Ukraines First Lady Kateryna Yushchenko Receives Inaugural MaxWell International Public Health Award
10. Emile Hirsch Visits the Democratic Republic of Congo With International Aid Agency Oxfam
11. Bruce Palsulich Joins Relsys International as Chief Innovation & Strategy Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s ... groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced ... J. Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage ...
(Date:12/8/2016)... , ... December 08, 2016 , ... Premier Fitness Camp ... FIT , the ultimate weight loss and wellness program, at their world headquarters of ... to provide immediate and long-term results to anyone seeking weight loss, personal development, a ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that it had joined the Pharmaceutical Supply Chain ... organization to unite pharmaceutical and healthcare companies that share a vision of better, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... California Senate Bill ... payments per workers’ compensation claim in 2013 and 2014, according to CompScope™ Medical ... Institute (WCRI) . , According to the study, medical payments per claim in California ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX ... Nationwide Children,s Hospital signed a membership ... accelerate the development of new cures. ... representing over 57 million patients globally, biopharmaceutical companies ... together to improve protocol design, site selection, patient ...
(Date:12/8/2016)... LAVAL, Quebec , Dec. 8, 2016 /PRNewswire/ ... and TSX: VRX) ("Valeant") today announced positive ... vehicle-controlled clinical study to assess the safety and ... in the treatment of plaque psoriasis. ... adult subjects with moderate to severe psoriasis, IDP-118 ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: